Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 2, 2026.

Vitamin D: beyond bone

Sylvia Christakos, Martin Hewison, David G. Gardner and 7 more

Annals of the New York Academy of Sciences · 2013

doi:10.1111/nyas.12129

Abstract

In recent years, vitamin D has been received increased attention due to the resurgence of vitamin D deficiency and rickets in developed countries and the identification of extraskeletal effects of vitamin D, suggesting unexpected benefits of vitamin D in health and disease, beyond bone health. The possibility of extraskeletal effects of vitamin D was first noted with the discovery of the vitamin D receptor (VDR) in tissues and cells that are not involved in maintaining mineral homeostasis and bone health, including skin, placenta, pancreas, breast, prostate and colon cancer cells, and activated T cells. However, the biological significance of the expression of the VDR in different tissues is not fully understood, and the role of vitamin D in extraskeletal health has been a matter of debate. This report summarizes recent research on the roles for vitamin D in cancer, immunity and autoimmune diseases, cardiovascular and respiratory health, pregnancy, obesity, erythropoiesis, diabetes, muscle function, and aging.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 60

  1. 1.

    Christakos S, DeLuca HF. Minireview: Vitamin D: is there a role in extraskeletal health? Endocrinology. 2011;152:2930-2936.

    Not in our library10.1210/en.2011-0243

  2. 2.

    Dhawan P, Wieder R, Christakos S. CCATT enhancer binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J. Biol. Chem. 2009;284:3086-3095.

    Not in our library10.1074/jbc.m803602200

  3. 3.

    Joshi S, Pantalena L-C, Liu XK, et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 2011;31:3653-3669.

    Not in our library10.1128/mcb.05020-11

  4. 4.

    Liu PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770-1773.

    Not in our library10.1126/science.1123933

  5. 5.

    Hewison M. Antibacterial effects of vitamin D. Nat. Rev. Endocrinol. 2011;7:337-345.

    Not in our library10.1038/nrendo.2010.226

  6. 6.

    Hewison M, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003;170:5382-5390.

    Not in our library10.4049/jimmunol.170.11.5382

  7. 7.

    Jeffery LE, et al. Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses. J. Immunol. 2012;189:5155-5164.

    Not in our library10.4049/jimmunol.1200786

  8. 8.

    Gardner DG, Chen S, Glenn DJ, Ni W, Pike DJWFeldman, Adams JS. Vitamin D and the Cardiovascular System. Vitamin D. 2011;541-563.

    Not in our library

  9. 9.

    Li YC, Kong J, Wei M, et al. 1,25-dihydroxyvitamin D(3) is a Negative Endocrine Regulator of the Renin-Angiotensin System. J. Clin. Invest. 2002;110:229-238.

    Not in our library10.1172/jci15219

  10. 10.

    Chen S, Gardner DG. Liganded Vitamin D Receptor Displays Anti-Hypertrophic Activity in the Murine Heart. J. Steroid. Biochem. Mol. Biol.

    Not in our library10.1016/j.jsbmb.2012.09.007

  11. 11.

    Chen S, Law CS, Grigsby CL, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124:1838-1847.

    Not in our library10.1161/circulationaha.111.032680

  12. 12.

    Hollis BW, Johnson D, Hulsey TC, et al. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone. Miner. 2011;26(10):2341-2357.

    Not in our library10.1002/jbmr.463

  13. 13.

    Mahomed K, Gulmezoglu AM. Vitamin D supplementation in pregnancy (Cochrane Review). Cochrane Database of Systematic Reviews. 1999.

    Not in our library10.1002/14651858.cd000228

  14. 14.

    De-Regil LM, Palacios C, Ansary A, et al. Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews. 2012;2:CD008873.

    Not in our library10.1002/14651858.cd008873.pub2

  15. 15.

    Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif. Tissue. Int. 2012.

    Not in our library10.1007/s00223-012-9607-4

  16. 16.

    Wagner CL, McNeil R, Hamilton SA, et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol. 2012.

    Not in our library10.1016/j.ajog.2012.10.888

  17. 17.

    Wagner CL, Hulsey TC, Fanning D, et al. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 2006;1:59-70.

    Not in our library10.1089/bfm.2006.1.59

  18. 18.

    Wagner CL, Howard C, Hulsey TC, et al. Preliminary Results of a Randomized Controlled Trial of Maternal Supplementation with 6400 IU Vitamin D/day Compared with Maternal & Infant Supplementation of 400 IU/day in Achieving Sufficiency in the Breastfeeding Mother-Infant Dyad. Intl. Society Res. Human Milk Lactation. 2012.

    Not in our library

  19. 19.

    Sergeev IN. Novel mediators of vitamin D signaling in cancer and obesity. Immun. Endoc. Metab. Agents Med. Chem. 2009;9:153-158.

    Not in our library

  20. 20.

    Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr. Res. Rev. 2012;25:130-141.

    Not in our library10.1017/s0954422412000029

  21. 21.

    Sergeev IN. Vitamin D and cellular Ca2+ signaling in breast cancer. Anticancer Res. 2012;32:299-302.

    Not in our library

  22. 22.

    Sergeev IN. Calcium signaling in cancer and vitamin D. J. Steroid Biochem. Mol. Biol. 2005;97:145-151.

    Not in our library10.1016/j.jsbmb.2005.06.007

  23. 23.

    Sergeev IN. 1,25-Dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem. Biophys. Res. Commun. 2009;384:18-24.

    Not in our library10.1016/j.bbrc.2009.04.078

  24. 24.

    Janssens W, et al. Vitamin D Beyond Bones in COPD: Time to Act. Am. J. Respir Crit. Care Med. 2009.

    Not in our library10.1164/rccm.200810-1576pp

  25. 25.

    Janssens W, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 65(3);215-220.

    Not in our library10.1136/thx.2009.120659

  26. 26.

    Romme EA, et al. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann. Med. 2012.

    Not in our library10.3109/07853890.2012.671536

  27. 27.
  28. 28.

    Forli L, et al. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J. Intern. Med. 2004;256(1):56-62.

    Not in our library10.1111/j.1365-2796.2004.01337.x

  29. 29.

    Hopkinson NS, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 2008;87(2):385-390.

    Not in our library10.1093/ajcn/87.2.385

  30. 30.

    Lehouck A, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2012;156(2):105-114.

    Not in our library10.7326/0003-4819-156-2-201201170-00004

  31. 31.

    Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792-3798.

    Not in our library10.1378/chest.128.6.3792

  32. 32.

    Kumar VA, Kujubu DA, Sim JJ, et al. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J. Nephrol. 2011;24(1):98-105.

    Not in our library10.5301/jn.2010.1830

  33. 33.

    Andrews NC. Anemia of inflammation:the cytokine-hepcidin link. J. Clin. Invest. 2004;113(9):1251-1253.

    Not in our library10.1172/jci21441

  34. 34.

    Howick J, Glasziou P, Aronson JK. The evolution of evidence hierarchies: what can Bradford Hill's ‘guidelines for causation’ contribute? J. Royal Soc. Med. 2009;102:186-194.

    Not in our library10.1258/jrsm.2009.090020

  35. 35.

    Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 2011;65:1005-1015.

    Not in our library10.1038/ejcn.2011.118

  36. 36.

    Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxyvitamin D concentration and incident Type 2 Diabetes: A meta-analysis of prospective studies diabetes care.

    Not in our library10.2337/dc12-0962

  37. 37.

    Pittas AG, et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980-986.

    Not in our library10.2337/dc06-1994

  38. 38.
  39. 39.

    Mitri J, et al. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 2011;94:486-494.

    Not in our library10.3945/ajcn.111.011684

  40. 40.

    Boland R. Role of vitamin D in skeletal muscle function. Endocr. Rev. 1986;7:434-448.

    Not in our library10.1210/edrv-7-4-434

All 60 references

Cited by papers we hold 6

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.